The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status

Abstract

An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has spread throughout China and received worldwide attention. On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. The emergence of SARS-CoV-2, since the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002 and Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, marked the third introduction of a highly pathogenic and large-scale epidemic coronavirus into the human population in the twenty-first century. As of 1 March 2020, a total of 87,137 confirmed cases globally, 79,968 confirmed in China and 7169 outside of China, with 2977 deaths (3.4%) had been reported by WHO. Meanwhile, several independent research groups have identified that SARS-CoV-2 belongs to β-coronavirus, with highly identical genome to bat coronavirus, pointing to bat as the natural host. The novel coronavirus uses the same receptor, angiotensin-converting enzyme 2 (ACE2) as that for SARS-CoV, and mainly spreads through the respiratory tract. Importantly, increasingly evidence showed sustained human-to-human transmission, along with many exported cases across the globe. The clinical symptoms of COVID-19 patients include fever, cough, fatigue and a small population of patients appeared gastrointestinal infection symptoms. The elderly and people with underlying diseases are susceptible to infection and prone to serious outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. Currently, there are few specific antiviral strategies, but several potent candidates of antivirals and repurposed drugs are under urgent investigation. In this review, we summarized the latest research progress of the epidemiology, pathogenesis, and clinical characteristics of COVID-19, and discussed the current treatment and scientific advancements to combat the epidemic novel coronavirus.

Cited by papers we hold 67

• Perspectives for restriction of dental treatment complexity during and after Covid-19 · 2022
  Not checked
• Short-term effects of COVID-19 on the risk of traumatic fractures in China cities · 2022
  Not checked
• Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis · 2022
  Not checked
• Hepatic and Pancreatic manifestations of COVID-19 · 2022
  Not checked
• Exploring changes in levels and patterns of physical activity in undergraduate medical and nursing students during the COVID-19 pandemic · 2022
  Not checked
• Deleterious effects of nervous system in the offspring following maternal SARS-CoV-2 infection during the COVID-19 pandemic · 2022
  Not checked
• New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review) · 2022
  Not checked
• Causal relationship between physical activity, leisure sedentary behaviors and COVID-19 risk: a Mendelian randomization study · 2022
  No notice
• Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification · 2022
  No notice
• Perceived impact of the COVID-19 pandemic on orthodontic practice in the Middle East · 2021
  Not checked
• Atitudes dos enfermeiros frente à morte: mudanças com a pandemia por COVID-19 · 2021
  Not checked
• Potential Nanospray Inhalation of Remdesivir and Hydroxychloroquine using Poly (lactic-co-glycolic) Acid as Fast Delivery for Covid-19 Treatment. · 2021
  Not checked
• Antivirals for COVID-19: A critical review · 2021
  Not checked
• PCR testing for COVID-19 in Health Center Zagreb-Center in year 2020: overview of testing criteria and results · 2021
  Not checked
• Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review · 2021
  Not checked
• Batik Production Village’s Adaptation on the Pandemic COVID-19 · 2021
  Not checked
• Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19 · 2021
  Not checked
• Current advances in the development of SARS-CoV-2 vaccines · 2021
  No notice
• The combined regimens of antiviral therapy might not be useful for the viral clearance of severe COVID-19 cases · 2021
  Not checked
• Handwashing knowledge, attitudes, and practices during the COVID-19 pandemic in Saudi Arabia: A non-representative cross-sectional study · 2021
  Not checked

and 47 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.